Allergy and COVID-19

The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult...

Descripción completa

Detalles Bibliográficos
Autores principales: De Filippo, Maria, Votto, Martina, Brambilla, Ilaria, Castagnoli, Riccardo, Montagna, Lorenza, Caffarelli, Carlo, Cardinale, Fabio, Miraglia Del Giudice, Michele, Tosca, Mariangela, Caimmi, Silvia, Licari, Amelia, Marseglia, Gian Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431895/
https://www.ncbi.nlm.nih.gov/pubmed/34842592
http://dx.doi.org/10.23750/abm.v92iS7.12402
Descripción
Sumario:The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult population, whereas a mild course was observed in childhood. Allergic diseases, characterized by a type-2 polarization of the immune system, were considered one of the major risk factor of severe COVID-19. Large amounts of clinical data and expert opinions have been collected since the pandemic outbreak. This review summarizes the latest insights on COVID-19 and allergy. (www.actabiomedica.it)

Ejemplares similares